ÂÜÀòÂÒÂ×

Pr. Chao He (Alex) is general manager of Medbot, a MicroPort’s robotics subsidiary. Founded in 1998 in Shanghai (China) with the common belief that advancements in medical technology can transform patients’ lives, MicroPort is a global leading developer, manufacturer and operator focusing on minimally invasive intervention products for the treatment of vascular diseases and pathological changes. Over the last two decades, MicroPort has taken important steps towards fulfilling its mission of providing access to the best means of prolonging and reshaping lives and today provides over 300 devices and technologies, currently approved for use in nearly 10,000 hospitals worldwide. At MicroPort innovation is part of our DNA¸ not only in the treatments and services we develop but also in the way we foster innovation. With a vast global footprint of R&D and manufacturing sites (Shanghai; Memphis (TN) in the United States; Clamart in France; Saluggia in Italy; Santo Domingo in Dominican Republic), a strong focus on technology innovation with over 4,000 patent applications, and a global workforce of over 7,000 employees, MicroPort is committed to its vision of building a People Centric Consortium of companies focused on Emerging Medical Technologies.